Literature DB >> 7517827

Lipoprotein metabolism. An overview.

J Shepherd1.   

Abstract

The biological benefits of lipids as sources of energy and precursors of cell components have led to the evolution of a complex plasma lipoprotein transport system, through which gram quantities of cholesterol, triglyceride, and phospholipid pass each day. A wide variety of tissues make demands on this pool. The adrenal glands and gonads avidly assimilate lipoprotein cholesterol for the production of steroid hormones, and rapidly dividing intestinal villus cells take up the sterol for membrane synthesis. Metabolically active tissues such as skeletal muscle use plasma triglyceride for energy production, while in times of surfeit this lipid is directed into adipocytes for storage. Two organs, the liver and intestine, play a particularly important role in corporeal lipid metabolism, and together are responsible for the majority of lipoprotein synthesis and catabolism. In the plasma, lipid transport is regulated by specific apolipoproteins (apo), lipoprotein receptors, lipolytic enzymes and transfer proteins, which act in concert to maintain the balance of cholesterol and triglyceride homeostasis in tissues and plasma; their malfunction may cause or contribute to the development of dyslipidaemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517827     DOI: 10.2165/00003495-199400472-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  44 in total

1.  Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.

Authors:  O D Mjos; O Faergeman; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

2.  Cholesterol 7 alpha-hydroxylase.

Authors:  N B Myant; K A Mitropoulos
Journal:  J Lipid Res       Date:  1977-03       Impact factor: 5.922

Review 3.  Lipoprotein receptors and cholesterol homeostasis.

Authors:  R W Mahley; T L Innerarity
Journal:  Biochim Biophys Acta       Date:  1983-05-24

Review 4.  Intestinal lipoprotein metabolism.

Authors:  P H Green; R M Glickman
Journal:  J Lipid Res       Date:  1981-11       Impact factor: 5.922

5.  Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins.

Authors:  E Windler; Y Chao; R J Havel
Journal:  J Biol Chem       Date:  1980-09-10       Impact factor: 5.157

6.  Human intestinal lipoproteins. Studies in chyluric subjects.

Authors:  P H Green; R M Glickman; C D Saudek; C B Blum; A R Tall
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Abnormal high density lipoproteins of abetalipoproteinemia: relevance to normal HDL metabolism.

Authors:  R J Deckelbaum; S Eisenberg; Y Oschry; M Cooper; C Blum
Journal:  J Lipid Res       Date:  1982-12       Impact factor: 5.922

8.  Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia.

Authors:  L A Carlson; L Holmquist; P Nilsson-Ehle
Journal:  Acta Med Scand       Date:  1986

9.  Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man.

Authors:  A Nicoll; B Lewis
Journal:  Eur J Clin Invest       Date:  1980-12       Impact factor: 4.686

10.  Heterogeneity of dog interstitial fluid (peripheral lymph) high density lipoproteins: implications for a role in reverse cholesterol transport.

Authors:  L Dory; L M Boquet; R L Hamilton; C H Sloop; P S Roheim
Journal:  J Lipid Res       Date:  1985-05       Impact factor: 5.922

View more
  5 in total

1.  A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport.

Authors:  W R Oliver; J L Shenk; M R Snaith; C S Russell; K D Plunket; N L Bodkin; M C Lewis; D A Winegar; M L Sznaidman; M H Lambert; H E Xu; D D Sternbach; S A Kliewer; B C Hansen; T M Willson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 2.  ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.

Authors:  Ioannis Akoumianakis; Evangelia Zvintzou; Kyriakos Kypreos; Theodosios D Filippatos
Journal:  Curr Atheroscler Rep       Date:  2021-03-10       Impact factor: 5.113

3.  Cobalt chloride decreases fibroblast growth factor-21 expression dependent on oxidative stress but not hypoxia-inducible factor in Caco-2 cells.

Authors:  Yanlong Liu; Chunhong Wang; Yuhua Wang; Zhenhua Ma; Jian Xiao; Craig McClain; Xiaokun Li; Wenke Feng
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-10       Impact factor: 4.219

4.  Histological, Immunohistochemical, and Biochemical Study of Experimentally Induced Fatty Liver in Adult Male Albino Rat and the Possible Protective Role of Pomegranate.

Authors:  Nadia F Hassan; Gehan M Soliman; Ebtsam F Okasha; Amany M Shalaby
Journal:  J Microsc Ultrastruct       Date:  2018 Jan-Mar

5.  Gender heterogeneity in dyslipidemia prevalence, trends with age and associated factors in middle age rural Chinese.

Authors:  Minmin Wang; Mengfei Liu; Fenglei Li; Chuanhai Guo; Zhen Liu; Yaqi Pan; Ying Liu; Fangfang Liu; Hong Cai; Yangfeng Wu; Zhonghu He; Yang Ke
Journal:  Lipids Health Dis       Date:  2020-06-12       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.